References
- Kridin K. Pemphigus group: overview, epidemiology, mortality, and comorbidities. Immunol Res. 2018;66(2):255–70. doi:https://doi.org/10.1007/s12026-018-8986-7.
- Didona D, Maglie R, Eming R, Hertl M. Pemphigus: current and future therapeutic strategies. Front Immunol. 2019;10:1–28.
- Ghodsi SZ, Chams-Davatchi C, Daneshpazhooh M, Valikhani M, Esmaili N. Quality of life and psychological status of patients with pemphigus vulgaris using Dermatology Life Quality Index and General Health Questionnaires. J Dermatol. 2012;39(2):141–4. doi:https://doi.org/10.1111/j.1346-8138.2011.01382.x.
- Cholera M, Chainani-Wu N. Management of pemphigus vulgaris. Adv Ther. 2016;33(6):910–58. doi:https://doi.org/10.1007/s12325-016-0343-4.
- Kridin K. Emerging treatment options for the management of pemphigus vulgaris. Ther Clin Risk Manag. 2018;14:757–78. doi:https://doi.org/10.2147/TCRM.S142471.
- International Pain Summit Of The International Association For The Study Of Pain. Declaration of Montréal: declaration that access to pain management is a fundamental human right. J Pain Palliat Care Pharmacother. 2011;25:29–31. doi:https://doi.org/10.3109/15360288.2010.547560.
- Brennan F, Lohman D, Gwyther L. Access to pain management as a human right. Am J Public Health. 2019;109(1):61–5. doi:https://doi.org/10.2105/AJPH.2018.304743.
- Raja SN, Carr DB, Cohen M, et al. The revised International Association for the Study of Pain definition of pain: concepts, challenges, and compromises. Pain. 2020;161(9):1976–82. doi:https://doi.org/10.1097/j.pain.0000000000001939.
- Treede RD, Rief W, Barke A, et al. Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11). Pain. 2019;160(1):19–27. doi:https://doi.org/10.1097/j.pain.0000000000001384.
- Yam MF, Loh YC, Tan CS, Adam SK, Manan NA, Basir R. General pathways of pain sensation and the major neurotransmitters involved in pain regulation. Int J Mol Sci. 2018;19:2164. doi:https://doi.org/10.3390/ijms19082164.
- Ong WY, Stohler CS, Herr DR. Role of the prefrontal cortex in pain processing. Mol Neurobiol. 2019;56(2):1137–66. doi:https://doi.org/10.1007/s12035-018-1130-9.
- Rashid RM, Candido KD. Pemphigus pain: a review on management. Clin J Pain. 2008;24(8):734–5. doi:https://doi.org/10.1097/AJP.0b013e31817af6fc.
- Vun YY, Lun K, Strutton G. Use of biosynthetic dressings in paraneoplastic pemphigus. Australas J Dermatol. 2004;45(2):133–5. doi:https://doi.org/10.1111/j.1440-0960.2004.00067.x.
- Yang C, Xu XM, He GZ. Efficacy and feasibility of opioids for burn analgesia: an evidence-based qualitative review of randomized controlled trials. Burns. 2018;44(2):241–8. doi:https://doi.org/10.1016/j.burns.2017.10.012.
- Raub JN, Vettese TE. Acute pain management in hospitalized adult patients with opioid dependence: a narrative review and guide for clinicians. J Hosp Med. 2017;12(5):375–9. doi:https://doi.org/10.12788/jhm.2733.
- WHO. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization, 2018.
- Dahan A. The importance of individual differences in response to opioid therapy. Therapy. 2009;6(5):633–5. doi:https://doi.org/10.2217/thy.09.44.
- Grosu I, Lavand’homme P. Use of dexmedetomidine for pain control. F1000 Med Rep. 2010;2:90–3. doi:https://doi.org/10.3410/M2-90.
- Linneman PK, Terry BE, Burd RS. The efficacy and safety of fentanyl for the management of severe procedural pain in patients with burn injuries. J Burn Care Rehabil. 2000;21(6):519–22. doi:https://doi.org/10.1097/00004630-200021060-00008.
- Widgerow AD, Kalaria S. Pain mediators and wound healing-establishing the connection. Burns. 2012;38(7):951–9. doi:https://doi.org/10.1016/j.burns.2012.05.024.
- Stapelberg F. Challenges in anaesthesia and pain management for burn injuries. Anaesth Intensive Care. 2020;48(2):101–13. doi:https://doi.org/10.1177/0310057X20914908.
- Caccavale S, Lo Schiavo A. Psychiatric morbidity and pemphigus: a review of theories and literature on pathogenesis. G Ital Dermatol Venereol. 2016;151(2):198–202.
- Wohl Y, Mashiah J, Kutz A, Hadj-Rabia S, Cohen AD. Pemphigus and depression comorbidity: a case control study. Eur J Dermatol. 2015;25(6):602–5. doi:https://doi.org/10.1684/ejd.2015.2649.
- Pedroni MN, Hirotsu C, Porro AM, Tufik S, Andersen ML. The role of sleep in pemphigus: a review of mechanisms and perspectives. Arch Dermatol Res. 2017;309(8):659–64. doi:https://doi.org/10.1007/s00403-017-1765-9.